Delia Cannings, Chair of the British Cleaning Council, discusses the importance of implementing and respecting robust cleaning protocols across different settings and why the UK Government must do more to make cleaning and hygiene a core part of the national agenda.
India broke records on Thursday (23 April) as more than 310,000 new COVID cases were documented in one day - is the Indian 'double mutation', B1617, as infectious as the UK mutation?
In February, 16% of the world's population pre-ordered 70% of available COVID vaccines - now, researchers at Colombia University reveal that some poorer countries won't be able to vaccinate their population until 2023.
The US is facing a fourth wave of COVID-19, as emergency healthcare workers across the country continue to face the virus and experience levels of burnout that can lead to PTSD.
We spoke with Dr Matthew Duchars, CEO of the UK’s first dedicated Vaccines Manufacturing and Innovation Centre (VMIC), about their work not only to provide an integral response to COVID-19, but as a centre of excellence advancing the vaccine sector on a global scale.
Jarek Salek, Head of Engineering and Technical Operations at Uvisan, explains how UV-C cleaning in educational facilities can make shared equipment safe from COVID and help resume teaching that involves computers and other shared hardware.
Professor Afaf El-Sagheer and Professor Tom Brown from the Department of Chemistry, Suez University and Oxford University describe their research, including the application of ‘click chemistry’ conjugation techniques to DNA.
There is a well-established diphtheria vaccine taken by millions of people, but researchers are now observing the disease evolving a resistance to antimicrobial treatment.
Professor Dr Apichart Vanavichit, at the Rice Science Center, reveals the hard solution to develop low glycemic rice for diabetes, starting with comment on soft-texture white rice as a health risk factor.
Andrew Metcalfe, Biotech Specialist at LumiBio discusses the persistent problem of hospital-acquired infections, and why now is the time to focus on reducing COVID- 19 transmission in clinical settings using the LumiBio solution.